The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/26601
StudyName: Eligibility Breast Cancer NCT00845910
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 21.10.2017
License: Creative Commons BY 4.0

----

Description: 
A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00845910
